Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications
- 31 December 2011
- journal article
- Published by Elsevier BV in Diabetes & Metabolism
- Vol. 37 (6), 512-519
- https://doi.org/10.1016/j.diabet.2011.04.002
Abstract
No abstract availableKeywords
Funding Information
- Mater Foundation
- Health Research Board (HRB RP/2004/220)
This publication has 35 references indexed in Scilit:
- Polygenic Risk Variants for Type 2 Diabetes Susceptibility Modify Age at Diagnosis in Monogenic HNF1A DiabetesDiabetes, 2009
- Exenatide-a potential role in treatment of HNF1-alpha MODY in obese patients?Diabetic Medicine, 2009
- Semi-Automated Unidirectional Sequence Analysis for Mutation Detection in a Clinical Diagnostic SettingGenetic Testing and Molecular Biomarkers, 2009
- A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patientsDiabetic Medicine, 2009
- Treatment of HNF1‐alpha MODY with the DPP‐4 inhibitor Sitagliptin1Diabetic Medicine, 2009
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008
- Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1α MutationsDiabetes Care, 2002
- Genetic testing in maturity onset diabetes of the young (MODY): a new challenge for the diabetic clinicPractical Diabetes International, 2001
- Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)Nature, 1996
- Diabetes Complications in NIDDM Kindreds Linked to the MODY3 Locus on Chromosome 12qDiabetes Care, 1996